Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AACH
AAC
$0.03
+46.8%
$0.03
$0.01
$0.84
$805KN/A96,753 shs891,800 shs
IMAC Holdings, Inc. stock logo
BACK
IMAC
$0.07
+13.3%
$0.05
$0.03
$2.10
$124K2.18676,049 shs1,756 shs
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
$0.00
$0.00
$0.00
$0.00
$5K0.9616,209 shs18,587 shs
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
$0.01
$0.01
$0.00
$0.01
$264K0.989,772 shsN/A
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AACH
AAC
0.00%0.00%0.00%0.00%0.00%
IMAC Holdings, Inc. stock logo
BACK
IMAC
+13.33%+13.33%+36.00%+87.33%-96.26%
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
0.00%0.00%0.00%-50.00%-98.33%
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
0.00%-11.11%+90.48%+2.56%+57.79%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AACH
AAC
N/AN/AN/AN/AN/AN/AN/AN/A
IMAC Holdings, Inc. stock logo
BACK
IMAC
N/AN/AN/AN/AN/AN/AN/AN/A
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AACH
AAC
0.00
N/AN/AN/A
IMAC Holdings, Inc. stock logo
BACK
IMAC
0.00
N/AN/AN/A
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
0.00
N/AN/AN/A
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AACH
AAC
N/AN/AN/AN/AN/AN/A
IMAC Holdings, Inc. stock logo
BACK
IMAC
$72.05K1.96N/AN/A($0.66) per share-0.10
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/AN/AN/AN/A
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
$30K8.79N/AN/A($0.99) per share-0.01
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AACH
AAC
N/AN/A0.00N/AN/AN/AN/AN/A
IMAC Holdings, Inc. stock logo
BACK
IMAC
-$9.42MN/A0.00N/AN/AN/A-325.44%8/4/2025 (Estimated)
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
-$39.76MN/A0.00N/AN/AN/AN/AN/A
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
-$3.85M-$0.13N/AN/AN/AN/A-96.09%N/A

Latest FCHS, AACH, BACK, and BTTX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
N/A-$0.04N/A-$0.04N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AACH
AAC
N/AN/AN/AN/AN/A
IMAC Holdings, Inc. stock logo
BACK
IMAC
N/AN/AN/AN/AN/A
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/AN/AN/A
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AACH
AAC
N/AN/AN/A
IMAC Holdings, Inc. stock logo
BACK
IMAC
N/A
0.08
0.08
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/A
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
AACH
AAC
N/A
IMAC Holdings, Inc. stock logo
BACK
IMAC
5.84%
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
34.00%
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
N/A

Insider Ownership

CompanyInsider Ownership
AACH
AAC
31.22%
IMAC Holdings, Inc. stock logo
BACK
IMAC
12.26%
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
51.40%
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
30.81%
CompanyEmployeesShares OutstandingFree FloatOptionable
AACH
AAC
1,90025.16 millionN/ANot Optionable
IMAC Holdings, Inc. stock logo
BACK
IMAC
1802.07 million1.82 millionNot Optionable
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
4049.86 million24.23 millionOptionable
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
20732.96 million22.80 millionNot Optionable

Recent News About These Companies

First Choice Healthcare Solutions Inc
Nasdaq hits first record high since July
2025 Subscriber Choice
Health systems top picks for clinical documentation
First Stop Health Launches New Whole Mental Health Program
First Health Hospice
Parrish Healthcare to take over Health First cancer center

Media Sentiment Over Time

Top Headlines

View All Headlines

AAC OTCMKTS:AACH

$0.03 +0.01 (+46.79%)
As of 12/14/2020

AAC Holdings, Inc. provides inpatient and outpatient substance use treatment services for individuals with drug addiction, alcohol addiction, and co-occurring mental/behavioral health issues in the United States. Its therapy services include motivational interviewing, cognitive behavioral therapy, rational emotive behavior therapy, dialectical behavioral therapy, solution-focused therapy, eye movement desensitization and reprocessing, and systematic family intervention. As of December 31, 2018, the company operated 11 inpatient substance abuse treatment facilities, focused on delivering clinical care and treatment solutions across 1,080 inpatient beds, including 700 licensed detoxification beds, 24 standalone outpatient centers, and 4 sober living facilities across 471 beds for a total of 1,551 combined inpatient and sober living beds. It also offers multi-media marketing services to families and individuals struggling with addiction and seeking treatment options through online directories of treatment providers, treatment provider reviews, forums, and professional communities. In addition, the company performs drug testing and diagnostic laboratory services; and provides physician services to its clients. AAC Holdings, Inc. was founded in 2014 and is headquartered in Brentwood, Tennessee. On June 20, 2020, AAC Holdings, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

IMAC stock logo

IMAC NASDAQ:BACK

$0.07 +0.01 (+13.33%)
As of 08/1/2025 03:30 PM Eastern

IMAC Holdings, Inc. owns and manages innovative medical advancements and care regeneration centers, and backspace clinics in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides medical treatments, regenerative, spinal decompression, chiropractic manipulation, and physical medicine and therapy. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Franklin, Tennessee.

Better Therapeutics stock logo

Better Therapeutics NASDAQ:BTTX

$0.0001 0.00 (0.00%)
As of 08/1/2025 01:40 PM Eastern

Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.

First Choice Healthcare Solutions stock logo

First Choice Healthcare Solutions OTCMKTS:FCHS

$0.0080 0.00 (0.00%)
As of 08/1/2025

First Choice Healthcare Solutions, Inc. provides healthcare services in the United States. It develops primary care and wellness clinics focused on providing life improvement services, such as anti-aging, weight management, hormone replacement, and pharmacy services. The company is headquartered in Melbourne, Florida.